Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

1.5K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

522
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
522
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

3.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.8K
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

239
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
239
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

234
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
234
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

773
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
773

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of a Y-introducer needle to increase the safety profile of pericardiocentesis.

Revista espanola de cardiologia (English ed.)·2026
Same author

Malignant ventricular arrhythmias during acute infectious illness: mechanisms, mapping, and targeted therapy - illustrative cases.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
Same author

Evaluation of cardiovascular morbidities in children and adolescents with lupus nephritis from south India: A cross-sectional analytical study.

Lupus·2026
Same author

A Rare Case of Dual, Decrementally Conducting, Pathway-to-Pathway-Mediated Tachycardia.

Pacing and clinical electrophysiology : PACE·2026
Same author

Left bundle cardiac resynchronization therapy versus left bundle optimized cardiac resynchronization therapy.

Indian pacing and electrophysiology journal·2026
Same author

Correlation of Conventional and Extended Lipid Profiles with Plaque Burden in Statin-naïve Patients with Acute Coronary Syndrome: A Prospective Observational Study from South India.

The Journal of the Association of Physicians of India·2025

Related Experiment Video

Updated: Dec 18, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Cardiovigilance in COVID 19.

Kamal Kishor1, Rishabh Marwah2, Avinash Anantharaj3

  • 1Department of Cardiology, Rama Hospital, Karnal.

JPMA. the Journal of the Pakistan Medical Association
|June 10, 2020
PubMed
Summary

The COVID-19 pandemic poses significant clinical challenges for cardiologists, impacting cardiac function and treatment. Vigilance is crucial for managing cardiovascular risks and complications associated with the disease and its therapies.

Keywords:
Cardiovascular, Conduction defects, Coronavirus, Diabetes, Heart failure, Myocarditis.

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.1K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

722

Related Experiment Videos

Last Updated: Dec 18, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.1K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

722

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic presents complex clinical challenges beyond its public health impact.
  • Cardiovascular dysfunction is a critical aspect of COVID-19, influencing risk, prognosis, diagnosis, and complications.

Purpose of the Study:

  • To review the multifaceted role of cardiac dysfunction in COVID-19.
  • To highlight the implications of cardiotropic drugs in COVID-19 pathogenesis.
  • To emphasize the occupational risks for cardiologists and the necessity of cardio vigilance.

Main Methods:

  • This is a review article.
  • It synthesizes current knowledge on COVID-19's cardiovascular manifestations.
  • It discusses clinical decision-making, drug effects, and transmission risks.

Main Results:

  • Cardiac dysfunction is integral to COVID-19's clinical spectrum.
  • Cardiotropic medications may contribute to COVID-19's pathogenesis.
  • Cardiologists face occupational transmission risks.

Conclusions:

  • Cardio vigilance is essential for effective COVID-19 management.
  • Understanding the cardiovascular impact is key for patient outcomes.
  • Addressing occupational hazards is vital for healthcare providers.